These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 15084636)

  • 21. Autoimmune hemolytic anemia and classical Hodgkin lymphoma: a case report and literature review.
    Feng Q; Zak D; Daya R
    Clin Adv Hematol Oncol; 2012 Apr; 10(4):270-6. PubMed ID: 22706493
    [No Abstract]   [Full Text] [Related]  

  • 22. How can outcomes be improved for older patients with Hodgkin lymphoma?
    Evens AM; Hong F
    J Clin Oncol; 2013 Apr; 31(12):1502-5. PubMed ID: 23509323
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemotherapy alone for early-stage Hodgkin's lymphoma.
    Straus DJ
    N Engl J Med; 2012 Feb; 366(5):470-1. PubMed ID: 22149920
    [No Abstract]   [Full Text] [Related]  

  • 24. Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease: 10-year results of a randomized trial.
    le Maignan C; Desablens B; Delwail V; Dib M; Berthou C; Vigier M; Ghandour C; Atmani S; Casassus P; Maisonneuve H; Le Mevel A; Traulle C; Bernard M; Briere J; Colonna P; Andrieu JM
    Blood; 2004 Jan; 103(1):58-66. PubMed ID: 12907440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current role and future developments of radiotherapy in early-stage favourable Hodgkin's lymphoma.
    Eich HT; Müller RP
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():16-8. PubMed ID: 18167000
    [No Abstract]   [Full Text] [Related]  

  • 26. Central nervous system Hodgkin lymphoma developing during systemic chemotherapy.
    Burrows SH; Mannari D
    Br J Haematol; 2016 Jan; 172(2):156. PubMed ID: 26455346
    [No Abstract]   [Full Text] [Related]  

  • 27. Feasibility and efficacy of dose-dense and dose-intense ABVD for high-risk patients with advanced Hodgkin lymphoma.
    D'Arco AM; Califano C; Barone L; Belsito Petrizzi V; Iovino V; Langella M; Maglione V; Rivellini F; De Lorenzo S
    Br J Haematol; 2015 Nov; 171(4):662-5. PubMed ID: 25873239
    [No Abstract]   [Full Text] [Related]  

  • 28. Angiokeratoma corporis diffusum in a patient with Hodgkin lymphoma: a new paraneoplastic skin manifestation?
    Han F; Wang P; Li Z; Zheng JH; Wang Q; Xu AE; Wang ZM
    Br J Dermatol; 2013 Jun; 168(6):1351-3. PubMed ID: 23278357
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
    Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.
    Sagar TG; Chandra A; Raman SG
    Med Pediatr Oncol; 2003 Jan; 40(1):66-9. PubMed ID: 12426693
    [No Abstract]   [Full Text] [Related]  

  • 31. A successful initiation of treatment of Hodgkin's lymphoma with adriamycin-bleomycin-vinblastine-dacarbazine dose reduction in a patient with fulminant hepatic failure and co-infection with human immunodeficiency virus and hepatitis B.
    Veeraballi S; Chan KH; Slim J; Shaaban HS; Guron G
    J Oncol Pharm Pract; 2022 Mar; 28(2):479-485. PubMed ID: 34590528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controversies in the treatment of early-stage Hodgkin's lymphoma.
    Longo DL; Armitage JO
    N Engl J Med; 2015 Apr; 372(17):1667-9. PubMed ID: 25901431
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of malignant lymphoma in childhood].
    Hattori T; Ishikawa Y; Nishi M; Nakadate H; Hatae Y; Takeda T
    Rinsho Ketsueki; 1985 Jan; 26(1):1-6. PubMed ID: 2582160
    [No Abstract]   [Full Text] [Related]  

  • 34. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
    Meyer RM; Gospodarowicz MK; Connors JM; Pearcey RG; Bezjak A; Wells WA; Burns BF; Winter JN; Horning SJ; Dar AR; Djurfeldt MS; Ding K; Shepherd LE; ;
    J Clin Oncol; 2005 Jul; 23(21):4634-42. PubMed ID: 15837968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous flagellate pigmentation by bleomycin.
    Spedini P; Bergonzi C; Morandi S
    Haematologica; 2000 Aug; 85(8):870. PubMed ID: 10942936
    [No Abstract]   [Full Text] [Related]  

  • 36. ABVD plus rituximab
    Strati P; Fanale MA; Oki Y; Turturro F; Fayad LE; Bartlett NL; Gladstone DE; Kasamon YL; Portlock CS; Wilson WH; Goy A; Younes A; Lee HJ
    Haematologica; 2019 Feb; 104(2):e65-e67. PubMed ID: 30190343
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined modality treatment of Hodgkin's lymphoma.
    Klimm B; Engert A
    Cancer J; 2009; 15(2):143-9. PubMed ID: 19390310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.
    Bonadonna G; Bonfante V; Viviani S; Di Russo A; Villani F; Valagussa P
    J Clin Oncol; 2004 Jul; 22(14):2835-41. PubMed ID: 15199092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A sinister itch: prurigo nodularis in Hodgkin lymphoma.
    Seshadri P; Rajan SJ; George IA; George R
    J Assoc Physicians India; 2009 Oct; 57():715-6. PubMed ID: 20329432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal treatment of early-stage Hodgkin disease.
    Sullivan JW; Cooper JS
    Radiology; 1993 Feb; 186(2):312-3. PubMed ID: 7678466
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.